NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, filed a Form N-CSR disclosing its schedule of portfolio holdings as of June 30,...
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces the acquisition of Daxor's BVA-100 blood volume analyzer as part of standard...
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces a new research initiative with a leading hospital in the Southeast using...
Tailwinds' Take: this is very positive for Daxor. If momentum starts to accelerate, DXR could be a great stock. We'd like to know if this is a one off event, or if the spigot is opening on a slew...
From the December lows of around $6, Daxor shares shot up more than 300% to a recent high of $20 in early March. The rally was, in my opinion, justified by the fundamental strength of their product, the BVA-100....
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces it will be exhibiting at the Annual Meeting of the American College...
Tailwinds Research - First off, let’s get into the data. You recently announced positive results at an industry conference. Can you speak about the significance of these?
Michael Feldschuh - The recent results at SCCM confirm that our test has...
Tailwinds' Take: we eventually expect to see a sharp uptick in growth from this already strong rate as the implications of the pivotal trial generate increased interest from the medical community. That likely starts to show itself this summer.
NEW...
Daxor Corporation
February 28, 2019
Dear Fellow Shareholder:
Daxor Corporation (“Daxor”or the “Company”) is an investment company with medical instrumentation and biotechnology operations. We have attached a report of our portfolio holdings and investment activity for the year ended December 31, 2018....
Tailwinds' Take: "Less blood draws, quicker results". This research further positions the BVA-100 as a must have for hospitals. The big catalyst here? We expect to start seeing these clinical results translate into sales in the near future. When...